Cargando…

The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders

BACKGROUND: Psychotic disorders are characterized by prominent deficits in associative learning and memory for which there are currently no effective treatments. Functional magnetic resonance imaging (fMRI) studies in psychotic disorders have identified deficits in fronto-temporal activation during...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakker, Geor, Vingerhoets, Claudia, Bloemen, Oswald J.N., Sahakian, Barbara J., Booij, Jan, Caan, Matthan W.A., van Amelsvoort, Thérèse A.M.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305431/
https://www.ncbi.nlm.nih.gov/pubmed/32563036
http://dx.doi.org/10.1016/j.nicl.2020.102278
_version_ 1783548459622596608
author Bakker, Geor
Vingerhoets, Claudia
Bloemen, Oswald J.N.
Sahakian, Barbara J.
Booij, Jan
Caan, Matthan W.A.
van Amelsvoort, Thérèse A.M.J.
author_facet Bakker, Geor
Vingerhoets, Claudia
Bloemen, Oswald J.N.
Sahakian, Barbara J.
Booij, Jan
Caan, Matthan W.A.
van Amelsvoort, Thérèse A.M.J.
author_sort Bakker, Geor
collection PubMed
description BACKGROUND: Psychotic disorders are characterized by prominent deficits in associative learning and memory for which there are currently no effective treatments. Functional magnetic resonance imaging (fMRI) studies in psychotic disorders have identified deficits in fronto-temporal activation during associative learning and memory. The underlying pathology of these findings remains unclear. Postmortem data have suggested these deficits may be related to loss of muscarinic M(1) receptor mediated signaling. This is supported by an in-vivo study showing improvements in these symptoms after treatment with the experimental M(1/4) receptor agonist xanomeline. The current study tests whether reported deficits in fronto-temporal activation could be mediated by loss of M(1) receptor signaling in psychotic disorders. METHODS: Twenty-six medication-free subjects diagnosed with a psychotic disorder and 29 age-, gender-, and IQ-matched healthy controls underwent two functional magnetic resonance imaging (fMRI) sessions, one under placebo and one under selective M(1) antagonist biperiden, while performing the paired associated learning task. M(1) binding potentials (BP(ND)) were measured in the dorsolateral prefrontal cortex (DLPFC) and hippocampus using (123)I-IDEX single photon emission computed tomography. RESULTS: In the subjects with psychotic disorders DLPFC hypoactivation was only found in the memory phase of the task. In both learning and memory phases of the task, M(1) antagonism by biperiden elicited significantly greater hyperactivation of the parahippocampal gyrus and superior temporal gyrus in subjects with a psychotic disorders compared to controls. Greater hyperactivation of these areas after biperiden was associated with greater hippocampal M(1) receptor binding during learning, with no association found with M(1) receptor binding in the DLPFC. M(1) receptor binding in the DLPFC was related to greater functional sensitivity to biperiden of the cingulate gyrus during the memory phase. CONCLUSION: The current study is the first to show differences in M(1) receptor mediated functional sensitivity between subjects with a psychotic disorder and controls during a paired associate learning and memory task. Results point to subjects with psychotic disorders having a loss of M(1) receptor reserve in temporal-limbic areas.
format Online
Article
Text
id pubmed-7305431
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73054312020-06-22 The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders Bakker, Geor Vingerhoets, Claudia Bloemen, Oswald J.N. Sahakian, Barbara J. Booij, Jan Caan, Matthan W.A. van Amelsvoort, Thérèse A.M.J. Neuroimage Clin Regular Article BACKGROUND: Psychotic disorders are characterized by prominent deficits in associative learning and memory for which there are currently no effective treatments. Functional magnetic resonance imaging (fMRI) studies in psychotic disorders have identified deficits in fronto-temporal activation during associative learning and memory. The underlying pathology of these findings remains unclear. Postmortem data have suggested these deficits may be related to loss of muscarinic M(1) receptor mediated signaling. This is supported by an in-vivo study showing improvements in these symptoms after treatment with the experimental M(1/4) receptor agonist xanomeline. The current study tests whether reported deficits in fronto-temporal activation could be mediated by loss of M(1) receptor signaling in psychotic disorders. METHODS: Twenty-six medication-free subjects diagnosed with a psychotic disorder and 29 age-, gender-, and IQ-matched healthy controls underwent two functional magnetic resonance imaging (fMRI) sessions, one under placebo and one under selective M(1) antagonist biperiden, while performing the paired associated learning task. M(1) binding potentials (BP(ND)) were measured in the dorsolateral prefrontal cortex (DLPFC) and hippocampus using (123)I-IDEX single photon emission computed tomography. RESULTS: In the subjects with psychotic disorders DLPFC hypoactivation was only found in the memory phase of the task. In both learning and memory phases of the task, M(1) antagonism by biperiden elicited significantly greater hyperactivation of the parahippocampal gyrus and superior temporal gyrus in subjects with a psychotic disorders compared to controls. Greater hyperactivation of these areas after biperiden was associated with greater hippocampal M(1) receptor binding during learning, with no association found with M(1) receptor binding in the DLPFC. M(1) receptor binding in the DLPFC was related to greater functional sensitivity to biperiden of the cingulate gyrus during the memory phase. CONCLUSION: The current study is the first to show differences in M(1) receptor mediated functional sensitivity between subjects with a psychotic disorder and controls during a paired associate learning and memory task. Results point to subjects with psychotic disorders having a loss of M(1) receptor reserve in temporal-limbic areas. Elsevier 2020-05-26 /pmc/articles/PMC7305431/ /pubmed/32563036 http://dx.doi.org/10.1016/j.nicl.2020.102278 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Bakker, Geor
Vingerhoets, Claudia
Bloemen, Oswald J.N.
Sahakian, Barbara J.
Booij, Jan
Caan, Matthan W.A.
van Amelsvoort, Thérèse A.M.J.
The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title_full The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title_fullStr The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title_full_unstemmed The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title_short The muscarinic M(1) receptor modulates associative learning and memory in psychotic disorders
title_sort muscarinic m(1) receptor modulates associative learning and memory in psychotic disorders
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305431/
https://www.ncbi.nlm.nih.gov/pubmed/32563036
http://dx.doi.org/10.1016/j.nicl.2020.102278
work_keys_str_mv AT bakkergeor themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT vingerhoetsclaudia themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT bloemenoswaldjn themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT sahakianbarbaraj themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT booijjan themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT caanmatthanwa themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT vanamelsvoortthereseamj themuscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT bakkergeor muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT vingerhoetsclaudia muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT bloemenoswaldjn muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT sahakianbarbaraj muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT booijjan muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT caanmatthanwa muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders
AT vanamelsvoortthereseamj muscarinicm1receptormodulatesassociativelearningandmemoryinpsychoticdisorders